Our data also indicate that CXCL8 is a significant prognostic biomarker associated with poor progression-free survival (PFS) in glioblastoma patients from the TCGA dataset and is a predictor of poor OS in the CGGA cohort. The gene discussed is CXCL8; the disease is glioblastoma.